Profile | GDS4284 / 224827_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2155.47 | 85 |
GSM687648 | Patient 402 control | 2010.77 | 84 |
GSM687653 | Patient 403 control | 2042.11 | 84 |
GSM687658 | Patient 404 control | 1239.69 | 77 |
GSM687663 | Patient 411 control | 1432.19 | 79 |
GSM687668 | Patient 422 control | 1602.22 | 81 |
GSM687673 | Patient 424 control | 1261.85 | 77 |
GSM687678 | Patient 425 control | 847.343 | 71 |
GSM687683 | Patient 427 control | 2066.49 | 84 |
GSM687688 | Patient 428 control | 1512.53 | 80 |
GSM687695 | Patient 441 control | 582.464 | 65 |
GSM687699 | Patient 443 control | 1516.48 | 80 |
GSM687704 | Patient 444 control | 1219.19 | 77 |
GSM687707 | Patient 448 control | 1470.89 | 80 |
GSM687712 | Patient 449 control | 1956.57 | 84 |
GSM687719 | Patient 450 control | 1633.27 | 81 |
GSM687724 | Patient 451 control | 2034.43 | 84 |
GSM687728 | Patient 452 control | 2091.93 | 85 |
GSM687646 | Patient 401 treated 24h | 1971.22 | 83 |
GSM687649 | Patient 402 treated 24h | 2147.68 | 84 |
GSM687665 | Patient 411 treated 24h | 1668.1 | 81 |
GSM687651 | Patient 402 treated 4 weeks | 1560.72 | 80 |
GSM687667 | Patient 411 treated 4 weeks | 1886.99 | 83 |
GSM687670 | Patient 422 treated 24h | 1653.34 | 81 |
GSM687671 | Patient 422 treated 4 weeks | 1341.22 | 78 |
GSM687654 | Patient 403 treated 24h | 2022.98 | 84 |
GSM687675 | Patient 424 treated 24h | 1270.51 | 77 |
GSM687685 | Patient 427 treated 24h | 2013.83 | 84 |
GSM687656 | Patient 403 treated 4 weeks | 1605.19 | 81 |
GSM687677 | Patient 424 treated 4 weeks | 1251.88 | 77 |
GSM687687 | Patient 427 treated 4 weeks | 1834.33 | 82 |
GSM687692 | Patient 428 treated 4h | 1455.48 | 79 |
GSM687716 | Patient 449 treated 4h | 1871.64 | 83 |
GSM687722 | Patient 450 treated 4h | 1973.78 | 84 |
GSM687680 | Patient 425 treated 24h | 898.105 | 72 |
GSM687690 | Patient 428 treated 24h | 2082.75 | 84 |
GSM687700 | Patient 443 treated 24h | 1223.27 | 77 |
GSM687705 | Patient 444 treated 24h | 1351.43 | 78 |
GSM687714 | Patient 449 treated 24h | 1717.23 | 82 |
GSM687721 | Patient 450 treated 24h | 1178.77 | 77 |
GSM687682 | Patient 425 treated 4 weeks | 1068.57 | 75 |
GSM687694 | Patient 428 treated 4 weeks | 1593.56 | 80 |
GSM687702 | Patient 443 treated 4 weeks | 2021.63 | 84 |
GSM687718 | Patient 449 treated 4 weeks | 1641.56 | 81 |
GSM687723 | Patient 450 treated 4 weeks | 2283.59 | 86 |
GSM687661 | Patient 404 treated 4h | 1429.21 | 79 |
GSM687710 | Patient 448 treated 4h | 1750.71 | 82 |
GSM687726 | Patient 451 treated 4h | 1891.41 | 83 |
GSM687730 | Patient 452 treated 4h | 1204.55 | 77 |
GSM687660 | Patient 404 treated 24h | 661.446 | 69 |
GSM687697 | Patient 441 treated 24h | 1072.82 | 76 |
GSM687709 | Patient 448 treated 24h | 1733.57 | 82 |
GSM687725 | Patient 451 treated 24h | 2196.9 | 85 |
GSM687729 | Patient 452 treated 24h | 1195.66 | 79 |
GSM687727 | Patient 451 treated 4 weeks | 2248.45 | 85 |
GSM687731 | Patient 452 treated 4 weeks | 1665.68 | 81 |